Impact News +++ General Mills, Worthington Enterprises And 3 Stocks To Watch Heading Into Wednesday (Benzinga) +++ WORTHINGTON ENTERPRISES Aktie +10,55%

HARVARD BIOSCIENCE Aktie

>HARVARD BIO Aktienkurs

0.457 EUR (Tradegate)

Ask: 0.464 EUR / 6458 Stück

Bid: 0.45 EUR / 6688 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

HARVARD BIO Aktie über LYNX handeln

Intraday

1 Jahr

>HARVARD BIO Performance

1 Woche: 0%

1 Monat: +39,4%

3 Monate: -25,4%

6 Monate: -79,4%

1 Jahr: -84,4%

laufendes Jahr: -78,1%

>HARVARD BIOSCIENCE Aktie

Name:

HARVARD BIOSCIENCE DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US4169061052 / 578107

Symbol/ Ticker:

HBI (Frankfurt) / HBIO (NASDAQ)

Kürzel:

FRA:HBI, ETR:HBI, HBI:GR, NASDAQ:HBIO

Index:

Webseite:

http://www.harvardbioscie..

Marktkapitalisierung:

19.39 Mio. EUR

Umsatz:

79.23 Mio. EUR

EBITDA:

2.57 Mio. EUR

Gewinn je Aktie:

-0.98 EUR

Schulden:

38.67 Mio. EUR

Liquide Mittel:

4.81 Mio. EUR

Umsatz-/ Gewinnwachstum:

-11.2% / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

0.24 / 1.51 / -

Gewinnm./ Eigenkapitalr.:

-63.52% / -138.8%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

HARVARD BIOSCIENCE, HARVARD BIO

Letzte Datenerhebung:

25.06.25

>HARVARD BIO Eigentümer

Aktien: 44.21 Mio. St.

f.h. Aktien: 33.97 Mio. St.

Insider Eigner: 8.27%

Instit. Eigner: 69.66%

Leerverk. Aktien: 15.23%

>HARVARD BIO Peer Group

ACHIEVE LIFE

CONVATEC ADR

CORVUS PHARMA

ELICIO

MYOMO

SEMLER SCIENTIFIC

SINOPHARM ADR

SONIDA

UNITY BIOTECHNOLOGY

ZIMVIE

>HARVARD BIO Chart & Kurs - NASDAQ

>HARVARD BIO News

02.06.25 - 23:00

Harvard Bioscience Appoints John Duke to Board of Directors (GlobeNewswire EN)

HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees. The Company also announced that Katherine Eade has been named Lead Independent Director of the Company's board of directors....

12.05.25 - 18:45	Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.05.25 - 13:12	Harvard Bioscience Non-GAAP EPS of -$0.01 beats by $0.03, revenue of $21.77M beats by $2.57M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.05.25 - 13:03	Harvard Bioscience Announces First Quarter 2025 Financial Results (GlobeNewswire EN)
	HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025....

05.05.25 - 22:48	Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET (GlobeNewswire EN)
	HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. ...

10.04.25 - 22:51	Harvard Bioscience announces CFO transition (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.03.25 - 21:03	Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 (GlobeNewswire EN)
	HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025:...

12.03.25 - 12:27	Harvard Bioscience beats top-line and bottom-line estimates; initiates Q1 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.03.25 - 12:24	Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire EN)
	HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2024....

24.02.25 - 22:48	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting (GlobeNewswire EN)
	Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity...

24.02.25 - 17:03	Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET (GlobeNewswire EN)
	HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2024, before the market opens on March 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. ...

13.01.25 - 23:57	Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference (GlobeNewswire EN)
	HOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Micro Cap Virtual Conference on January 22nd, 2025, with a presentation time of 10:00 am ET....

06.12.24 - 15:24	Harvard Bioscience files $100M mixed securities shelf (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.24 - 13:57	Harvard Bioscience Non-GAAP EPS of -$0.02 misses by $0.03, revenue of $21.97M misses by $1.73M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.24 - 17:48	Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience (Zacks)
	Mettler-Toledo International and Harvard Bioscience are part of the Zacks Industry Outlook article....

29.10.24 - 22:03	Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET (GlobeNewswire EN)
	HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. ...

18.09.24 - 13:36	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting (GlobeNewswire EN)
	Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development...

05.09.24 - 22:06	Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference (GlobeNewswire EN)
	HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation time of 9:15 am ET....

08.08.24 - 15:06	Harvard Bioscience Non-GAAP EPS of $0.00 misses by $0.05, revenue of $23.1M misses by $3.3M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.08.24 - 14:33	Harvard Bioscience Announces Second Quarter 2024 Financial Results (GlobeNewswire EN)
	HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2024....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram